Abstract:The off-target effects of <i>Streptococcus pyogenes</i> Cas9 (SpCas9) pose a significant challenge to harness it as a therapeutical approach. Two major factors can result in SpCas9 off-targeting: tolerance to target DNA-guide RNA (gRNA) mismatch and less stringent recognition of protospacer adjacent motif (PAM) flanking the target DNA. Despite the abundance of engineered SpCas9-gRNA variants with improved sensitivity to target DNA-gRNA mismatch, studies focusing on enhancing SpCas9 PAM recognition stringency are quite few. A recent pioneering study identified a D1135E variant of SpCas9 that exhibits much-reduced editing activity at the noncanonical NAG/NGA PAM sites while preserving robust on-target activity at the canonical NGG-flanking sites (N is any nucleobase). Herein, we aim to clarify the molecular mechanism by which this single D1135E mutation confers on SpCas9 enhanced specificity for PAM recognition by molecular dynamics simulations. The results suggest that the variant maintains the base-specific recognition for the canonical NGG PAM via four hydrogen bonds, akin to that in the wild type (WT) SpCas9. While the noncanonical NAG PAM is engaged to the two PAM-interacting arginine residues (i.e., R1333 and R1335) in WT SpCas9 via two to three hydrogen bonds, the D1135E variant prefers to establish two hydrogen bonds with the PAM bases, accounting for its minimal editing activity on the off-target sites with an NAG PAM. The impaired NAG recognition by D1135E SpCas9 results from the PAM duplex displacement such that the hydrogen bond of R1333 to the second PAM base is disfavored. We further propose a mechanistic model to delineate how the mutation perturbs the noncanonical PAM recognition. We anticipate that the mechanistic knowledge could be leveraged for continuous optimization of SpCas9 PAM recognition specificity toward high-precision demanding applications.

Diverse noncanonical PAMs recognized by SpCas9 in human cells

Expanding PAM recognition and enhancing base editing activity of Cas9 variants with non‐PI domain mutations derived from xCas9

Comparison of Non-Canonical PAMs for CRISPR/Cas9-mediated DNA Cleavage in Human Cells

In-depth assessment of the PAM compatibility and editing activities of Cas9 variants

Evolved Cas9 variants with broad PAM compatibility and high DNA specificity

Efficient Cleavage Resolves PAM Preferences of CRISPR-Cas in Human Cells.

Potential high-frequency off-target mutagenesis induced by CRISPR/Cas9 in Arabidopsis and its prevention

Engineer Chimeric Cas9 to Expand PAM Recognition Based on Evolutionary Information

SaCas9 Requires 5'-NNGRRT-3' PAM for Sufficient Cleavage and Possesses Higher Cleavage Activity Than SpCas9 or FnCpf1 in Human Cells.

A Cas9 with PAM recognition for adenine dinucleotides

Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease

Molecular Mechanism of D1135E-Induced Discriminated CRISPR-Cas9 PAM Recognition

Engineered CRISPR-Cas9 nucleases with altered PAM specificities

Quantification of the affinities of CRISPR–Cas9 nucleases for cognate protospacer adjacent motif (PAM) sequences

Identification of SaCas9 orthologs containing a conserved serine residue that determines simple NNGG PAM recognition

Compact SchCas9 Recognizes the Simple NNGR PAM

Base Editing-Coupled Survival Screening Enabled High-Sensitive Analysis of PAM Compatibility and Finding of the New Possible Off-Target

Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants

Structural insights into a high fidelity variant of SpCas9

Genome editing with natural and engineered CjCas9 orthologs

Mechanism of expanded DNA recognition in xCas9